Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3027)
All Articles published online
|
Dec 14, 2005 (publication date) through May 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hong X, Yu RB, Sun NX, Wang B, Xu YC, Wu GL. Human leukocyte antigen class II DQB1*0301, DRB1*1101 alleles and spontaneous clearance of hepatitis C virus infection: A meta-analysis. World J Gastroenterol 2005; 11(46): 7302-7307 [PMID: 16437632 DOI: 10.3748/wjg.v11.i46.7302] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i46/7302.htm |
| Number | Citing Articles |
| 1 |
Robert Thimme, Christoph Neumann-Haefelin, Tobias Boettler, Hubert E. Blum. Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine. bchm 2008; 389(5): 457 doi: 10.1515/BC.2008.061
|
| 2 |
R. Buchanan, T. Hydes, S. I. Khakoo. Innate and adaptive genetic pathways in HCV infection. Tissue Antigens 2015; 85(4): 231 doi: 10.1111/tan.12540
|
| 3 |
P. Muñoz de Rueda, S. M. Jiménez-Ruiz, R. Quiles, E. J. Pavón-Castillero, J. A. Muñoz-Gámez, J. Casado, A. Gila, A. Ruiz-Extremera, J. Salmerón. The antigenic variability of HCV in viral HLA-Ag binding is related to the activation of the host immune response. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-15605-0
|
| 4 |
Rong‐Bin Yu, Xin Hong, Wei‐Liang Ding, Yong‐Fei Tan, Yong‐Xiang Zhang, Nan‐Xiong Sun, Guan‐Ling Wu, Sheng‐Wei Zhan, Da‐Fang Ge. The association between the genetic polymorphism of HLA‐DQA1, DQB1, and DRB1 and serum alanine aminotransferase levels in chronic hepatitis C in the Chinese population. Journal of Gastroenterology and Hepatology 2008; 23(9): 1394 doi: 10.1111/j.1440-1746.2007.05215.x
|
| 5 |
Mario Frias, Antonio Rivero-Juárez, Pedro López-López, Antonio Rivero. Pharmacogenetics and the Treatment of HIV-/HCV-Coinfected Patients. Pharmacogenomics 2018; 19(12): 979 doi: 10.2217/pgs-2018-0046
|
| 6 |
A. V. Marangon, R. A. Moliterno, A. M. Sell, C. F. V. de Moraes, R. M. T. Grotto, M. C. Pardini, D. S. De Pauli, J. E. L. Visentainer, G. F. Silva. Influence of HLA alleles in response to treatment with pegylated interferon‐alpha and ribavirin in patients with chronic hepatitis C. International Journal of Immunogenetics 2012; 39(4): 296 doi: 10.1111/j.1744-313X.2012.01088.x
|
| 7 |
Maemu P Gededzha, M Jeffrey Mphahlele, Selokela G Selabe. Prediction of T-cell epitopes of hepatitis C virus genotype 5a. Virology Journal 2014; 11(1) doi: 10.1186/1743-422X-11-187
|
| 8 |
Leland J. Yee, KyungAh Im, Abdus S. Wahed, Teodorica Bugawan, Jia Li, Shannon L. Rhodes, Henry Erlich, Hugo R. Rosen, T. Jake Liang, Huiying Yang. Polymorphism in the Human Major Histocompatibility Complex and Early Viral Decline during Treatment of Chronic Hepatitis C. Antimicrobial Agents and Chemotherapy 2009; 53(2): 615 doi: 10.1128/AAC.00947-08
|
| 9 |
L. Ali, A. Mansoor, N. Ahmad, S. Siddiqi, K. Mazhar, A. G. Muazzam, R. Qamar, K. M. Khan. Patient HLA-DRB1* and -DQB1* allele and haplotype association with hepatitis C virus persistence and clearance. Journal of General Virology 2010; 91(8): 1931 doi: 10.1099/vir.0.018119-0
|
| 10 |
Jenefer M. Blackwell, Sarra E. Jamieson, David Burgner. HLA and Infectious Diseases. Clinical Microbiology Reviews 2009; 22(2): 370 doi: 10.1128/CMR.00048-08
|
| 11 |
Yinan Yao, Mei Liu, Feng Zang, Ming Yue, Xueshan Xia, Yue Feng, Haozhi Fan, Yun Zhang, Peng Huang, Rongbin Yu. Association betweenhuman leucocyte antigen-DOpolymorphisms and interferon/ribavirin treatment response in hepatitis C virus type 1 infection in Chinese population: a prospective study. BMJ Open 2018; 8(4): e019406 doi: 10.1136/bmjopen-2017-019406
|
| 12 |
Zane Lombard, Desiré-Lee Dalton, Philip A. Venter, Robert C. Williams, Liza Bornman. Association of HLA-DR, -DQ, and Vitamin D Receptor Alleles and Haplotypes with Tuberculosis in the Venda of South Africa. Human Immunology 2006; 67(8): 643 doi: 10.1016/j.humimm.2006.04.008
|
| 13 |
Raffaele Bruno, Paolo Sacchi. Spontaneous Hepatitis C Virus Clearance in HIV‐Infected Patients: New Insights for Improving Management. The Journal of Infectious Diseases 2008; 198(9): 1262 doi: 10.1086/592173
|
| 14 |
M. El‐Bendary, M. Neamatallah, G. Esmat, E. Kamel, H. Elalfy, T. Besheer, D. Eldeib, A.‐H. Eladl, M. El‐Setouhy, A.‐H. El‐Gilany, A. El‐Waseef. Associations of human leucocyte antigen class II‐DQB1 alleles with hepatitis C virus infection in Egyptian population: a multicentre family‐based study. Journal of Viral Hepatitis 2016; 23(12): 961 doi: 10.1111/jvh.12573
|
| 15 |
Olfat Shaker, Heba Bassiony, Maissa El Raziky, Samer S. El-Kamary, Gamal Esmat, Akmal M. El-Ghor, Mona M. Mohamed. Human Leukocyte Antigen Class II Alleles (DQB1 and DRB1) as Predictors for Response to Interferon Therapy in HCV Genotype 4. Mediators of Inflammation 2013; 2013: 1 doi: 10.1155/2013/392746
|
| 16 |
Shafiq Ur Rehman, Mahd Rauf, Zaigham Abbas, Muhammed Haroon Hamed, Ishtiaq Qadri. Role of Some Predominant Host Immunomodulators' Single Nucleotide Polymorphisms in Severity of Hepatitis B Virus and Hepatitis C Virus Infection. Viral Immunology 2016; 29(10): 536 doi: 10.1089/vim.2016.0062
|
| 17 |
Kentaro Matsuura, Yasuhito Tanaka. Host genetic variants influencing the clinical course of hepatitis C virus infection. Journal of Medical Virology 2016; 88(2): 185 doi: 10.1002/jmv.24334
|
| 18 |
Bo Zhou, Li Yang, Liansheng Wang, Yanping Shi, Huaijun Zhu, Naping Tang, Bin Wang. The association of tea consumption with ovarian cancer risk: A metaanalysis. American Journal of Obstetrics and Gynecology 2007; 197(6): 594.e1 doi: 10.1016/j.ajog.2007.05.027
|
| 19 |
Paloma Muñoz de Rueda, Miguel-Ángel López-Nevot, Pablo Sáenz-López, Jorge Casado, Antonia Martín-Casares, Pablo Palomares, Rosa Quiles, Ana Gila, Manuel Romero-Gómez, Esther-José Pavón, José-Antonio Muñoz, Ángel Carazo, Paloma Sanz-Cameno, Ricardo Moreno-Otero, Moisés Diago, Josefa León, Ángeles Ruiz-Extremera, Javier Salmerón. Importance of Host Genetic Factors HLA and IL28B as Predictors of Response to Pegylated Interferon and Ribavirin. American Journal of Gastroenterology 2011; 106(7): 1246 doi: 10.1038/ajg.2011.82
|
| 20 |
Mustafa Gökhan Ertosun, Özlenen Özkan, Şule Darbaş, Deniz Özel, Uğur BİLGE, Nurten Sayin Ekinci, Vural Taner Yilmaz, Fahri Uçar, Hüseyin Koçak, Ömer Özkan. The relationship between COVID‐19 and HLA in kidney transplant recipients, an evaluation of predictive and prognostic factors. Clinical Transplantation 2022; 36(2) doi: 10.1111/ctr.14525
|
| 21 |
Sayo E. McCowin, G. Brett Moreau, Rashidul Haque, Janelle A. Noble, Shana L. McDevitt, Jeffrey R. Donowitz, Md Masud Alam, Beth D. Kirkpatrick, William A. Petri, Chelsea Marie. HLA class I and II associations with common enteric pathogens in the first year of life. EBioMedicine 2021; 67: 103346 doi: 10.1016/j.ebiom.2021.103346
|
| 22 |
Farha A. El-Chennawi, Fatma A. Auf, Shereen S. Metwally, Youssef M. Mosaad, Mohamed A. El-Wahab, Ziyad E. Tawhid. HLA-Class II Alleles in Egyptian Patients with Hepatocellular Carcinoma. Immunological Investigations 2008; 37(7): 661 doi: 10.1080/08820130802111605
|
| 23 |
Frank Grünhage, Jacob Nattermann. Viral hepatitis: Human genes that limit infection. Best Practice & Research Clinical Gastroenterology 2010; 24(5): 709 doi: 10.1016/j.bpg.2010.07.009
|
| 24 |
A. V. Marangon, G. F. Silva, C. F. V. de Moraes, R. M. T. Grotto, M. I. M. C. Pardini, D. S. de Pauli, J. E. L. Visentainer, A. M. Sell, R. A. Moliterno. Protective Effect of HLA‐DRB1*11 and Predisposition of HLA‐C*04 in the Development of Severe Liver Damage in Brazilian Patients with Chronic Hepatitis C Virus Infection. Scandinavian Journal of Immunology 2012; 76(4): 440 doi: 10.1111/j.1365-3083.2012.02755.x
|
| 25 |
Rebecca A. Harris, Kazushi Sugimoto, David E. Kaplan, Fusao Ikeda, Malek Kamoun, Kyong‐Mi Chang. Human leukocyte antigen class II associations with hepatitis C virus clearance and virus‐specific CD4 T cell response among Caucasians and African Americans. Hepatology 2008; 48(1): 70 doi: 10.1002/hep.22287
|
| 26 |
Alajos Pár. Genetic polymorphisms as the predictors of response to antiviral treatment in chronic hepatitis C virus infection. Orvosi Hetilap 2011; 152(22): 876 doi: 10.1556/OH.2011.29113
|
| 27 |
R. Thimme, C. Neumann-Haefelin. Genetics in Liver Diseases. Falk Symposium 2007; 156: 18 doi: 10.1007/978-1-4020-6393-0_4
|
| 28 |
Zehui Yan, Yuming Wang. Viral and host factors associated with outcomes of hepatitis C virus infection. Molecular Medicine Reports 2017; 15(5): 2909 doi: 10.3892/mmr.2017.6351
|
| 29 |
Alessandra Mangia, Rosanna Santoro, Roberto Sarli, Leonardo Mottola, Valeria Piazzolla, Daniela Petruzzellis, Donato Bacca, Rocco Clemente, Massimiliano Copetti, Lazzaro di Mauro, Giuseppe Lotti, Michele Sacco, Ippazio Stefano. Il28B Cc-Genotype Association with Hla-Dqb1*0301 Allele Increases the Prediction of Spontaneous HCV RNA Clearance in Thalassaemic HCV-Infected Patients. Antiviral Therapy 2011; 16(8): 1309 doi: 10.3851/IMP1913
|
| 30 |
Zhongsheng Guo, Henghui Zhang, Huiying Rao, Dong Jiang, Xu Cong, Bo Feng, Jianghua Wang, Lai Wei, Hongsong Chen, Jianqing Xu. DCs Pulsed with Novel HLA-A2-Restricted CTL Epitopes against Hepatitis C Virus Induced a Broadly Reactive Anti-HCV-Specific T Lymphocyte Response. PLoS ONE 2012; 7(6): e38390 doi: 10.1371/journal.pone.0038390
|
| 31 |
Marzyeh Amini, Hossein Poustchi. Hepatitis C Virus Spontaneous Clearance: Immunology and Genetic Variance. Viral Immunology 2012; 25(4): 241 doi: 10.1089/vim.2011.0052
|
| 32 |
Safa Machraoui, Khaoula Errafii, Ider Oujamaa, Moulay Yassine Belghali, Abdelmalek Hakmaoui, Saad Lamjadli, Fatima Ezzohra Eddehbi, Ikram Brahim, Yasmine Haida, Brahim Admou. Frequency of the Main Human Leukocyte Antigen A, B, DR, and DQ Loci Known to Be Associated with the Clearance or Persistence of Hepatitis C Virus Infection in a Healthy Population from the Southern Region of Morocco: A Preliminary Study. Diseases 2024; 12(5): 106 doi: 10.3390/diseases12050106
|
| 33 |
Malik Sallam, Roaa Khalil. Contemporary Insights into Hepatitis C Virus: A Comprehensive Review. Microorganisms 2024; 12(6): 1035 doi: 10.3390/microorganisms12061035
|
| 34 |
Bruna C. Bertol, Simone Moreira, Raquel F. L. Garcia, Leslie E. Ferreira, Guilherme Debortoli, Mauro de Souza Leite Pinho, Marcia Amendola-Pires, Alessandra M. de Almeida Maciel, Carlos E. Brandço-Mello, Paulo H. C. de França. IL28B gene polymorphisms in mono- and HIV-coinfected chronic hepatitis C patients. Frontiers in Microbiology 2015; 6 doi: 10.3389/fmicb.2015.00153
|
| 35 |
Xinjian Zhang, Jun Dou, Markus W. Germann. Characterization of the cellular immune response in hepatitis C virus infection. Medicinal Research Reviews 2009; 29(6): 843 doi: 10.1002/med.20157
|
| 36 |
C Neumann-Haefelin, R Thimme. Impact of the genetic restriction of virus-specific T-cell responses in hepatitis C virus infection. Genes & Immunity 2007; 8(3): 181 doi: 10.1038/sj.gene.6364368
|
| 37 |
Thomas Tu, Keyur Patel, Nicholas A. Shackel. Genomic and Precision Medicine. 2017; : 317 doi: 10.1016/B978-0-12-800685-6.00017-5
|
| 38 |
Jieting Huang, Ke Huang, Ru Xu, Min Wang, Qiao Liao, Huaping Xiong, Chengyao Li, Xi Tang, Zhengang Shan, Ming Zhang, Xia Rong, Kenrad Nelson, Yongshui Fu. The Associations of HLA-A*02:01 and DRB1*11:01 with Hepatitis C Virus Spontaneous Clearance Are Independent of IL28B in the Chinese Population. Scientific Reports 2016; 6(1) doi: 10.1038/srep31485
|
| 39 |
L. O. F. Cangussu, R. Teixeira, E. F. Campos, G. F. Rampim, S. A. Mingoti, O. A. Martins‐Filho, M. Gerbase‐DeLima. HLA Class II Alleles and Chronic Hepatitis C Virus Infection. Scandinavian Journal of Immunology 2011; 74(3): 282 doi: 10.1111/j.1365-3083.2011.02568.x
|
| 40 |
Julia Schmidt, Robert Thimme, Christoph Neumann-Haefelin. Host Genetics in Immune-Mediated Hepatitis C Virus Clearance. Biomarkers in Medicine 2011; 5(2): 155 doi: 10.2217/bmm.11.19
|
| 41 |
Karen Fitzmaurice, Jacob Hurst, Megan Dring, Andri Rauch, Paul J McLaren, Huldrych F Günthard, Clair Gardiner, Paul Klenerman. Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection. Gut 2015; 64(5): 813 doi: 10.1136/gutjnl-2013-306287
|
| 42 |
Mahmoud El-Bendary, Mustafa Neamatallah, Hatem Elalfy, Tarek Besheer, Emily Kamel, Hend Mousa, Abdel-Hamid Eladl, Maged El-Setouhy, Abdel-Hady El-Gilany, Ahmed El-Waseef, Gamal Esmat. HLA Class II-DRB1 Alleles with Hepatitis C Virus Infection Outcome in Egypt: A Multicentre Family-based Study. Annals of Hepatology 2019; 18(1): 68 doi: 10.5604/01.3001.0012.7864
|
| 43 |
Jonathan R. Honegger, Dana Tedesco, Jennifer A. Kohout, Mona R. Prasad, Aryn A. Price, Tera Lindquist, Samantha Ohmer, Melissa Moore-Clingenpeel, Arash Grakoui, Christopher M. Walker.
Influence of
IFNL3
and
HLA-DPB1
genotype on postpartum control of hepatitis C virus replication and T-cell recovery
. Proceedings of the National Academy of Sciences 2016; 113(38): 10684 doi: 10.1073/pnas.1602337113
|
| 44 |
JINMEI HUANG, LIANGSHI XIONG, JIN WANG, YONGFANG LIU, QIRONG ZHU, JUN LEI, ZHONGHUI ZHOU. Association between the HLA-DQB1 polymorphisms and the susceptibility of chronic hepatitis B: A comprehensive meta-analysis. Biomedical Reports 2016; 4(5): 557 doi: 10.3892/br.2016.632
|
| 45 |
|
| 46 |
Beth D. Kirkpatrick, Rashidul Haque, Priya Duggal, Dinesh Mondal, Cathy Larsson, Kristine Peterson, Jasmin Akter, Lauren Lockhart, Salwa Khan, William A. Petri, Jr.. Association betweenCryptosporidiumInfection and Human Leukocyte Antigen Class I and Class II Alleles. The Journal of Infectious Diseases 2008; 197(3): 474 doi: 10.1086/525284
|
| 47 |
Hossein Ghaderi-Zefrehi, Mohammad Gholami-Fesharaki, Amir Ghorbanzadeh, Farzin Sadeghi. Association of HLA Class II Alleles with Outcome of Hepatitis C Virus Infection: A Systematic Review and Meta-analysis. Hepatitis Monthly 2021; 21(7) doi: 10.5812/hepatmon.109493
|
| 48 |
Paul Shapshak, Charurut Somboonwit, Lydia N. Drumright, Simon D.W. Frost, Deborah Commins, Timothy L. Tellinghuisen, William K. Scott, Robert Duncan, Clyde McCoy, J. Bryan Page, Brian Giunta, Francisco Fernandez, Elyse Singer, Andrew Levine, Alireza Minagar, Oluwadayo Oluwadara, Taiwo Kotila, Francesco Chiappelli, John T. Sinnott. Molecular and Contextual Markers of Hepatitis C Virus and Drug Abuse. Molecular Diagnosis & Therapy 2009; 13(3): 153 doi: 10.1007/BF03256323
|
| 49 |
Mariko Ishibashi, Hiromi Yamaguchi, Yukari Hirotani, Akihisa Sakurada, Toshihide Endo, Masahiko Sugitani, Tadatoshi Takayama, Makoto Makishima, Mariko Esumi. Contradictory intrahepatic immune responses activated in high-load hepatitis C virus livers compared with low-load livers. Archives of Virology 2018; 163(4): 855 doi: 10.1007/s00705-017-3675-8
|
| 50 |
M Amills, O Ramírez, A Tomàs, G Obexer-Ruff, O Vidal. Positive selection on mammalian MHC-DQ genes revisited from a multispecies perspective. Genes & Immunity 2008; 9(8): 651 doi: 10.1038/gene.2008.62
|
| 51 |
Hisham O. Akbar. Can chronic hepatitis C resolve spontaneously? Case report and review. Arab Journal of Gastroenterology 2011; 12(1): 51 doi: 10.1016/j.ajg.2011.01.010
|
| 52 |
E Łoś-Rycharska, A Szaflarska-Popławska. Influence of selected HLA tissue compatibility antigens on the course and efficacy of viral hepatitis C treatment - actual knowledge position. Advances in Medical Sciences 2009; 54(1) doi: 10.2478/v10039-009-0002-y
|
| 53 |
Yanzhen Xu, Nanfang Mo, Zhiwen Jiang, Shaoming Lu, Shien Fu, Xinyan Wei, Dong Zhao, Zhibin Xie, Wenxian Jia, Jiayi Liu, Xiao Wang, Dongchen Shi, Yang Jiao, Chengwu Liu, Xiaoli Yang. Human leukocyte antigen (HLA)-DRB1 allele polymorphisms and systemic sclerosis. Modern Rheumatology 2019; 29(6): 984 doi: 10.1080/14397595.2018.1519148
|
| 54 |
B. S. de Almeida, G. M. Fabrício Silva, P. M. da Silva, R. de Mello Perez, F. A. F. Figueiredo, L. C. Porto. Ethnicity and route of HCV infection can influence the associations of HLA with viral clearance in an ethnically heterogeneous population. Journal of Viral Hepatitis 2011; 18(10): 692 doi: 10.1111/j.1365-2893.2010.01429.x
|
| 55 |
Robert Thimme, Marco Binder, Ralf Bartenschlager. Failure of innate and adaptive immune responses in controlling hepatitis C virus infection. FEMS Microbiology Reviews 2012; 36(3): 663 doi: 10.1111/j.1574-6976.2011.00319.x
|
| 56 |
Rumki Das, Sanjay B. Rathod, Kalichamy Alagarasu, Vidya A. Arankalle, Anuradha S. Tripathy. Altered expressions of peripheral CD11c, CD80, CD83 markers and associations of HLA class II allele and haplotypes in self-limiting Hepatitis E infection. Human Immunology 2013; 74(3): 277 doi: 10.1016/j.humimm.2012.12.010
|
| 57 |
Chloe L. Thio. Host Genetic Factors and Antiviral Immune Responses to Hepatitis C Virus. Clinics in Liver Disease 2008; 12(3): 713 doi: 10.1016/j.cld.2008.03.002
|
| 58 |
Ming Yue, Ke Xu, Meng-Ping Wu, Ya-Ping Han, Peng Huang, Zhi-Hang Peng, Jie Wang, Jing Su, Rong-Bin Yu, Jun Li, Yun Zhang. Human Leukocyte Antigen Class II Alleles Are Associated with Hepatitis C Virus Natural Susceptibility in the Chinese Population. International Journal of Molecular Sciences 2015; 16(8): 16792 doi: 10.3390/ijms160816792
|